Apaf1 plays a pro-survival role by regulating centrosome morphology and function by Ferraro, Elisabetta et al.
Apaf1 plays a pro-survival role by regulating
centrosome morphology and function
Elisabetta Ferraro1,2,*, Maria Grazia Pesaresi3, Daniela De Zio2, Maria Teresa Cencioni4, Anne Gortat5,
Mauro Cozzolino3, Libera Berghella6, Anna Maria Salvatore7, Bjorn Oettinghaus8, Luca Scorrano8,
Enrique Pe´rez-Paya`5 and Francesco Cecconi1,2,`
1Laboratory of Molecular Neuroembryology, IRCCS Fondazione Santa Lucia, 00143, Rome, Italy
2Dulbecco Telethon Institute, Department of Biology, University of Rome ‘Tor Vergata’, 00133, Rome, Italy
3Laboratory of Neurochemistry, IRCCS Fondazione Santa Lucia, 00143, Rome, Italy
4Laboratory of Neuroimmunology, IRCCS Fondazione Santa Lucia, 00143, Rome, Italy
5Department of Medicinal Chemistry, Centro de Investigacio´n Prı´ncipe Felipe, 46012 Valencia, Spain and IBV-CSIC, E-46010, Valencia, Spain
6Hospital San Raffaele Sulmona, 67039, Sulmona (AQ), Italy
7Institute of Neurobiology and Molecular Medicine, CNR 00137, Rome, Italy
8Department of Cell Physiology and Metabolism, University of Geneva, 1206, Geneva, Switzerland
*Present address: Laboratory of skeletal muscle development and metabolism, IRCCS San Raffaele, 00163 Rome, Italy
`Author for correspondence (francesco.cecconi@uniroma2.it)
Accepted 27 June 2011
Journal of Cell Science 124, 3450–3463
 2011. Published by The Company of Biologists Ltd
doi: 10.1242/jcs.086298
Summary
The apoptotic protease activating factor 1 (Apaf1) is the main component of the apoptosome, and a crucial factor in the mitochondria-
dependent death pathway. Here we show that Apaf1 plays a role in regulating centrosome maturation. By analyzing Apaf1-depleted
cells, we have found that Apaf1 loss induces centrosome defects that impair centrosomal microtubule nucleation and cytoskeleton
organization. This, in turn, affects several cellular processes such as mitotic spindle formation, cell migration and mitochondrial network
regulation. As a consequence, Apaf1-depleted cells are more fragile and have a lower threshold to stress than wild-type cells. In fact, we
found that they exhibit low Bcl-2 and Bcl-XL expression and, under apoptotic treatment, rapidly release cytochrome c. We also show
that Apaf1 acts by regulating the recruitment of HCA66, with which it interacts, to the centrosome. This function of Apaf1 is carried out
during the cell life and is not related to its apoptotic role. Therefore, Apaf1 might also be considered a pro-survival molecule, whose
absence impairs cell performance and causes a higher responsiveness to stressful conditions.
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Introduction
The apoptotic protease activating factor 1 (Apaf1) is one of
the most studied proapoptotic proteins. It is the core of the
apoptosome, which is formed upon triggering of the
mitochondrial apoptotic pathway. Following an apoptotic
induction, cytochrome c is released from mitochondria, it binds
Apaf1 and induces a conformational change of this protein,
which is able to oligomerize and to recruit and activate
procaspase-9 (Zou et al., 1997). Recently, Kroemer and
coworkers have identified a novel role for Apaf1, which is
independent of its function in the cell death machinery. Indeed,
they have found that Apaf1 is involved in the maintenance of
genomic stability upon DNA damage (Mouhamad et al., 2007;
Zermati et al., 2007).
The centrosome is a major microtubule-organizing center
(MTOC) in animal cells. Microtubules mainly nucleate from the
surface of centrosomes, which are formed by a pair of centrioles
surrounded by a pericentriolar material. One of several proteins
forming the pericentriolar material is c-tubulin; it catalyzes the
nucleation of microtubule polymers from a–b-tubulin dimers. In
association with several gamma complex proteins (GCPs), c-
tubulin can form two complexes, namely a small c-TuSC (c-
tubulin small complex) and a large ring-shaped complex, c-TuRC
(c-tubulin ring complex). c-Tubulin moves from the cytosol to
the centrosomes, the recruitment of c-tubulin to the centrosomes
being regulated by kinases, by proteins of the pericentriolar
material and by a protein binding the c-TuRC called NEDD1
(neural precursor cell expressed, developmentally downregulated
1) (Haren et al., 2006; Luders et al., 2006; Oegema et al., 1999).
Recently it has been found that the hepatocellular carcinoma
antigen 66 (HCA66), which had been previously described as an
interactor of Apaf1 and a positive regulator of Apaf1-dependent
apoptosis (Piddubnyak et al., 2007), is required for the stability of
c-TuSC proteins and that its deficiency affects spindle
microtubule assembly (Fant et al., 2009).
Centrosomes are important for division: during S phase, the
centrosome duplicates and the two centrosomes separate to form
the poles of the mitotic spindle. At this point, c-tubulin
recruitment to each centrosome increases; this enhances the
centrosome microtubule nucleation capacity and a microtubule
aster is formed. Following nuclear envelope breakdown,
microtubules originated from centrosomes, attach to the
kinetochores of chromosomes, and mitosis can proceed
(Fukasawa, 2007; Jaspersen and Stearns, 2008; Mazia, 1987).
Microtubules and centrosomes also play an important role in
cell migration, which is a process stringently regulated during
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tissue development, chemotaxis and wound healing (Kodani and
Sutterlin, 2008; Noritake et al., 2005; Watanabe et al., 2005).
Moreover, the microtubule cytoskeleton is essential for the
organization and movement of organelles such as the Golgi
complex (Thyberg and Moskalewski, 1999). The distribution and
organization of the endoplasmic reticulum (ER) also depends on
interactions with microtubules, and one level of regulation of
mitochondria (besides fission and fusion) is their active transport
along microtubules (Jahani-Asl et al., 2010; Park and Blackstone,
2010). In addition, microtubules are essential for vesicle
transport, because vesicles use the microtubule network to meet
and fuse with several different endocytic organelles (Hehnly and
Stamnes, 2007). Besides their function as organizers of the
cytoskeleton and the mitotic spindle, centrosomes serve also as
spatiotemporal organizers of events regulating cell cycle,
probably by triggering G1 to S transition checkpoints (Rai et
al., 2008; Rieder et al., 2001).
In this paper, we show that Apaf1 has a role in centrosome
stability, because it favors the recruitment of HCA66, the
stabilizer of the c-TuSC, to the centrosomes. In the absence of
Apaf1, association of HCA66 with the centrosomes is poor;
aberrant centrosomes are thus formed and this impairs
microtubule nucleation. We also show that, as a consequence
of Apaf1 deficiency, several biological processes are affected,
such as the formation of a normal bipolar mitotic spindle, cell
division, cell migration and mitochondrial network organization.
Moreover, anti-apoptotic proteins are downregulated in Apaf1-
depleted cells, which, in fact, rapidly release cytochrome c upon
apoptotic treatment. For these reasons, we suggest that the
absence of Apaf1 makes cells more fragile and more sensitive to
stress. Thus, from this viewpoint, Apaf1 has to be also considered
a pro-survival protein in addition to its pro-apoptotic role.
Results
Apaf1-deficient cells release cytochrome c with a faster
kinetics than that of WT cells
We have previously reported that Apaf1-deficient proneural
ETNA [embryonic telencephalic naı¨ve Apaf1 knockout (Apaf1-
KO)] and ETNA cells overexpressing a dominant-negative form
of caspase-9 (C9DN-ETNA) – two cell lines devoid of a
functional apoptosome and therefore resistant to apoptosis – are
both able to survive with an active metabolism for a long time
before undergoing a non-apoptotic form of cell death (Ferraro et
al., 2008). By continuous analysis of the behavior of these two
apoptosome-deficient cell lines, we made a challenging
observation: upon apoptotic treatment with tunicamycin (an
inhibitor of N-linked glycosylation) plus the proteasome inhibitor
MG132, which is needed to avoid cytochrome c degradation after
its release, many more ETNA KO cells than C9DN-ETNA cells
released cytochrome c (Fig. 1A,E).
In order to understand whether this difference was due to the
overexpression of the dominant-negative form of caspase-9 or to
the absence of Apaf1, we performed the same kind of analysis on
wild-type ETNA cells (ETNA WT). We observed that WT cells
behaved like C9DN-ETNA cells and showed, upon apoptotic
treatment, a much lower release of cytochrome c than Apaf1-
knockout cells (Fig. 1A,E). Accordingly, as reported in Fig. 1B,
the percentage of cells with dissipated mitochondrial membrane
potential (DYm) (Fig. 1B Tun; red line, left peak) was notably
higher in Apaf12/2 cells compared with ETNA-WT and C9DN-
ETNA cells under the same apoptotic treatment. Such a
difference between Apaf1-deficient ETNA cells and WT and
C9DN-ETNA cells indicated that the faster kinetics of
cytochrome c release was not due to the absence of a
functional apoptosome or to the overexpression of C9DN but,
instead, to the absence of Apaf1.
To ascertain whether the high susceptibility to mitochondrial
damage was a general consequence of Apaf1 depletion or
whether it was merely a clonal effect, we analyzed other SV40
antigen-transformed cell lines, i.e. Apaf1-depleted and wild-type
immortalized mouse embryonic fibroblasts (I-Mefs KO and I-
Mefs WT). Also in this context we found, in mutant cells under
tunicamycin treatment, many more cytochrome-c-releasing cells
and cells with depolarized mitochondria when compared with
WT cells (Fig. 1C–E). As an alternative pro-apoptotic stimulus,
we used the mRNA transcription inhibitor actinomycin D and
confirmed the difference between Apaf1-KO and WT genotypes,
which, we conclude, was not dependent on the apoptotic stimulus
used (Fig. 2). Interestingly, also under normal conditions (where
very rare spontaneous apoptotic cells are generally found) more
cytochrome-c-releasing cells are detectable in Apaf1-KO I-Mefs
(Fig. 2, I-Mefs KO Ctrl, arrow).
Therefore, these experiments suggest that Apaf1-deficient cells
are more sensitive than WT cells to apoptotic insults.
Anti-apoptotic proteins are downregulated in Apaf1-
deficient cells
In order to understand why the absence of Apaf1 makes cells
more susceptible to mitochondrial damage we analyzed
expression levels of the anti-apoptotic proteins Bcl-2 and Bcl-
XL. Both proteins belong to the Bcl-2 family, which is in charge
of regulating mitochondrial outer membrane permeabilization
(MOMP) and, as a consequence, cytochrome c release from
mitochondria (Danial and Korsmeyer, 2004). Interestingly, in
line with our observations, we found that the expression of these
anti-apoptotic proteins is lower in all Apaf1-deficient cell lines
analyzed than in their WT counterparts (Fig. 3A,B). In ETNA
cells the absence of Bcl-2 downregulation might be compensated
by the strong downregualtion of Bcl-XL expression in the balance
between genes that control apoptosis (Lotem and Sachs, 1995).
Because Bcl-2 and Bcl-XL might be transcriptionally regulated
(Catz and Johnson, 2001; Sevilla et al., 2001) we also checked,
by means of a quantitative real-time PCR analysis of their mRNA
levels, whether their downregulation was also evident at a
transcriptional level. We found that the lower expression of Bcl-2
and Bcl-XL was also due to a transcriptional downregulation
(Fig. 3B). To confirm the effect of Apaf1 deficiency on Bcl-2
and Bcl-XL expression, we went on to evaluate the amount of
both proteins in mouse embryonic brains [embryonic day
(E)14.5] and we found that both protein and mRNA levels
were downregulated in Apaf1-deficient embryos as well
(Fig. 3A–C).
Therefore, Apaf1-KO cells express low amount of anti-
apoptotic proteins, which might explain their lower threshold in
MOMP regulation.
Along with a fast kinetics of cytochrome c release, Apaf1-
deficient cells show mitochondrial fragmentation
Because Apaf1-depleted cells show fast kinetics of cytochrome c
release, and because release of cytochrome c has been proposed
to be favored by mitochondrial fission [although the debate on
this topic is still open (reviewed by Scorrano, 2009)], we set out
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to establish whether the mitochondrial network in Apaf1-KO cells
was altered. By staining mitochondria in untreated WT and
Apaf1-KO I-Mefs, we clearly observed in KO cells a strong
mitochondrial fragmentation (Fig. 4A), which was not evident in
the small cytosol of ETNA cells (data not shown). Dynamin
related protein 1 (Drp1) is a GTPase that mediates mitochondrial
fission through translocation from microtubules to the
mitochondria. Moreover, when phosphorylated at Ser616, Drp1
stimulates mitochondrial fission (Scorrano, 2009; Varadi et al.,
2004). By separating the mitochondrial and cytosolic fractions of
cells, we found that Drp1 localization at mitochondria in Apaf1-
deficient cells is greater than in WT cells, in both I-Mefs and
ETNA lines (Fig. 4B,C). We also found that the amount of Drp1
phosphorylated at Ser616 is higher in Apaf1-KO I-Mefs and
ETNA cells than in WT cells (Fig 4B,C). These experiments
confirm that there is more mitochondrial fission in KO cells.
Apaf1 depletion leads to impairment of centrosomal
microtubule nucleation
The experiments described so far led us to the conclusion that
Apaf1 deficiency makes cells more prone to activate apoptotic
signaling and to quickly release cytochrome c; however, Apaf1-
deficient cells do not undergo apoptosis because their
apoptosome cannot be formed (Ferraro et al., 2008). The
Fig. 1. Fast kinetics of cytochrome c release and DYm
dissipation in Apaf1-depleted cells.
(A,C) Immunofluorescence staining for the detection of
cytochrome c (green) in C9DN-ETNA, ETNA KO and
ETNA WT cells untreated (Ctrl) or treated with 3 mg/ml
tunicamycin plus 2 mM MG132 for 40 hours (Tun; A) and
in I-Mefs KO and I-Mefs WT cells treated for 20 hours
with 2 mg/ml tunicamycin (Tun; C). White arrows
indicate cells with cytochrome c released into the cytosol,
and yellow arrows indicate cells with cytochrome c within
the mitochondria. Notably, when ETNA-WT, C9DN-
ETNA and ETNA KO cells were treated with the caspase
inhibitor Q-VD-OPH, to avoid cell detachment from the
dish, the same results were obtained (data not shown).
Scale bar, 20 mm. (B) C9DN-ETNA, ETNA KO and
ETNA WT and (D) I-Mefs KO and I-Mefs WT cells
untreated (Ctrl, yellow curve), treated with 10 mM
carbonyl cyanide-p-trifluoromethoxyphenylhydrazone
(FCCP; an uncoupler that dissipates the transmembrane
potential by preventing the generation of a proton
gradient, used as a control for mitochondrial
depolarization; blue curve) or treated with tunicamycin
(Tun, red curve) were stained with 50 nM
tetramethylrhodamine ethyl ester (TMRE,
MolecularProbes) for 10 minutes, washed and then
analyzed by flow cytometry on a FACScan (Becton
Dickinson) in FL-2 for DYm measurement. Note that in
ETNA KO cells there is a marked depolarization of the
mitochondria (Tun, red curve). (E) Quantitative analysis
of the number of cells releasing cytochrome c upon the
treatments described in A and C, and represented by
histograms each indicating the means ¡ s.e.m. of three
independent experiments. In all, at least 100 cells were
analyzed in each field examined and five randomly chosen
fields for each experimental condition were counted.
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increased mitochondrial fission could partly explain the fragility
of KO cell mitochondria and the easy release of cytochrome c
that we observed. The hypothesis is, therefore, that the absence of
Apaf1 favors apoptosis initiation and that Apaf1 has an important
prosurvival role in the cell other than the apoptotic one.
If this turns out to be the case, Apaf1-deficient cells could
show features of fragility, functional impairment or
morphological abnormalities. In fact, close examination of
Apaf1-deficient cells reveals a number of differences in the
shape compared with WT cells. This gross observation and the
fact that the cytoskeleton has an important role in regulating
mitochondrial network shape (which we found is altered in
Apaf1-deficient cells), prompted us to examine cytoskeleton
organization. Mitochondria do indeed interact with
microfilaments, intermediate filaments and microtubules and,
normally, a high proportion (60–70%) of the single mitochondria
are located along microtubules (Varadi et al., 2004). We stained
actin stress fibers with phalloidin and microtubules with an anti-
b-tubulin antibody. No apparent differences in actin cytoskeletal
architecture were found between WT and Apaf12/2 cells
(Fig. 5A). By contrast, the distribution of the tubulin network
showed significant aberrations in Apaf1-deficient cells (Fig. 5B):
whereas in control cells microtubules originate predominantly
from the centrosomes, forming a radial network, in Apaf1-
depleted cells the majority of microtubules appeared
disorganized and nucleation did not originate from a single
centrosomal aster-shaped focus (Fig. 5B). Apaf1 deficiency
causes defects in the organization of the microtubule
cytoskeleton in primary Mefs also, but the effect is milder than
in immortalized cells (data not shown).
To clearly assess whether the absence of Apaf1 cells causes
defects in centrosomal microtubule nucleation, we perfomed a
microtubule re-growth assay after cold depolymerization. This
experiment confirmed that, in Apaf1-deficient cells, microtubules
nucleation from the centrosome is impaired and that centrosome
asters are not visible, although the formation of cytoplasmic
microtubules is not affected and microtubule density is similar to
that in controls (Fig. 5C). By contrast, in WT cells, microtubules
have a radial, centrosome-based organization and microtubule
asters appear very well defined in most cells (Fig. 5C). The
results obtained with ETNA cells were similar (data not shown).
Taken together, these results suggest that Apaf1 might have a
role in regulating centrosomal microtubule nucleation.
Efficient centrosome and mitotic spindle formation
requires Apaf1
Given the impaired microtubule nucleation observed in Apaf1-
deficient cells, we analyzed the centrosome components and we
found that in both Apaf12/2 I-Mef and ETNA cells, there was
less centrosome-bound c-tubulin staining than in WT cells
(Fig. 6A,B,E). This indicates that Apaf1 plays a role in
centrosome maturation. In addition to the centrosomal c-tubulin
staining observed using immunofluorescence, we also measured
the amount of total c-tubulin by western blot analysis of cell
lysates; we observed that the overall amount of the protein was
similar in Apaf12/2 cells compared with WT cells (data not
shown). This means that the depletion of Apaf1 affects only the
recruitment of c-tubulin to centrosomes.
Because centrosomes are the main MTOC of cells and because
spindle formation and mitosis depend on them, we decided to
analyze mitotic spindle formation in Apaf1-deficient cells. We
stained the mitotic spindle with an anti-b-tubulin antibody and
visualized DNA with DAPI or with an anti-phosphorylated
histone H3 (P-H3) antibody. We found that most of the WT cells
had normal mitotic bipolar spindles with aligned DNA in the
metaphase plate. By contrast, most KO cells had an abnormal
phenotype with disorganized spindles: bipolar spindle with
misaligned DNA or multipolar or monocentric spindle
(Fig. 6C–F).
We also analyzed mitosis by videorecording the cells and we
observed that whereas WT I-Mef cells have a highly regular
shape during mitosis, KO I-Mefs have longer mitoses and a
deformed morphology, in particular during metaphase and
anaphase (Fig. 7A). We observed a similar phenomenon in
ETNA cells (Fig. 7B). More specifically, we measured the length
of metaphase and anaphase, when the role of the spindle is
Fig. 2. Faster kinetics of cytochrome c release in Apaf1-depleted cells
compared with WT cells is not dependent on the kind of apoptotic
stimulus applied. Double-labeling immunofluorescence microscopy of I-
Mefs WT and I-Mefs KO, not treated (Ctrl) or treated for 20 hours with
10 mM actinomycin D (ActD). Cytochrome c staining (green) and the merged
images of cytochrome c and manganese superoxide dismutase 1 (MnSOD;
red), used as marker of mitochondrial localization are shown. White arrows
indicate cells with released cytochrome c. Scale bar: 25 mm.
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clearly relevant, and we found that this stage of mitosis lasts, on
average, 18.5 and 28 minutes in WT and KO I-Mefs,
respectively, and 26 and 36 minutes in WT and ETNA KO
cells, respectively (Fig. 7A,B). We can conclude that, in the
absence of Apaf1, cells are still able to enter mitosis but with a
lower efficiency of correct mitotic division compared with WT
Fig. 3. Apaf1-deficient cells exhibit a low
expression of the anti-apoptotic factors
Bcl-2 and Bcl-XL. (A) Western blot
analysis of Bcl-2 and Bcl-XL expression in
total cell lysates of wild type (WT) and
knockout (KO) immortalized Mefs
(I-Mefs), primary Mefs (Mefs), ETNA
(ETNA) cells and E14.5 embryonic brains
(Embryonic Brain). b-Actin was also
assayed as a control of equal protein
loading. (B) Densitometric analyses were
performed using the software AlphaEaseFC
(Alpha-Innotech), normalized for b-actin
and reported as arbitrary units (a.u.). Values
are means ¡ s.e.m. of the densitometric
analysis of three independent immunoblots.
(C) The mRNA levels of Bcl-XL or Bcl-2
were evaluated by quantitative real-time
PCR and were normalized to b-actin, used
as an internal control. Values are the fold
changes (means ¡ s.e.m.; n53) of Bcl-XL
or Bcl-2 mRNA relative to control cells,
which was arbitrarily set as 1.
Fig. 4. Mitochondrial fragmentation is increased in
Apaf1-depleted cells. (A) Immunofluorescence staining
of cytochrome c (green) to reveal mitochondrial
morphology in WT and Apaf1-KO I-Mefs. Scale bar:
5 mm. (B) Apaf1-KO and WT I-Mefs and ETNA
mitochondria fractions and total extracts were subjected
to SDS-PAGE and analyzed for Drp1 and
phosphorylated Drp1 (p-Drp1; at Ser616) protein levels,
respectively. Tom20 or VDAC and b-actin were assayed
as loading controls in mitochondrial and total extracts.
(C) Densitometric analyses of immunoblots shown in B
were calculated using the software AlphaEaseFC,
normalized for Tom20 or for VDAC (mitochondrial
markers) or for b-actin and are reported as arbitrary units
(a.u.). Values are means ¡ s.e.m. of the densitometric
analysis of four independent immunoblots.
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cells, as featured by the longer time to complete mitosis and the
irregular shape of dividing cells (Fig. 7A,B). From these data, we
also observed that Apaf1-KO cells proliferate more slowly than
WT cells.
The mitotic spindle is essential for accurate chromosome
segregation, and centrosome abnormalities are often associated
with chromosomal instability. In some cases, centrosomal
impairment can lead to aberrant mitosis that is unable to
undergo completion thanks to checkpoints that trigger cell
death. Indeed, although Apaf1-depleted cells do not undergo
apoptosis, some cells die by other types of cell death, as shown
by propidium iodide staining in conditions of Apaf1 deficiency
(Fig. 7C, subG1). In other cases, although cytokinesis occurs and
daughter cells are viable, these suffer severe aneuploidy or fail
cytokinesis and continue to cycle, becoming large multinucleated
polyploid cells with supernumerary centrosomes, as we found in
ETNA KO cells (supplementary material Fig. S1).
Apaf1-deficient cells are defective in cell migration
Because centrosomes and microtubule assembly and dynamics
are also important for cell motility (Kodani and Sutterlin, 2008;
Watanabe et al., 2005), we also analyzed cell migration in Apaf1-
depleted cells. We performed a wound-healing assay and we
observed that, after 20 hours, WT I-Mefs had almost filled the
wound made by a scratch between cells. By contrast, KO cells
were much slower to migrate into the wound (Fig. 8A,B). In
particular, even though we observed a movement of Apaf1-
depleted cells toward the wound soon after the scratch, they
subsequently slowed down, showing a trend to interact laterally
with the other cells in order to first completely fill the space
between cells and, only later, migrating toward the wound
(Fig. 8A). Moreover, immunofluorescence of c-tubulin
30 minutes after the scratch indicated that there were fewer
Apaf1-deficient I-Mefs than WT cells with centrosomes oriented
toward the wound edge (Fig. 8C). Thus, on the basis of these
results, it can be concluded that Apaf1 influences cell migration
most probably through its effects on centrosomes and on
microtubule assembly and dynamics.
Apaf1 absence reduces the recruitment of HCA66 and
other centrosomal proteins to centrosomes
One possible explanation of the role of Apaf1 in regulating
centrosomal stability, which is needed for cell division and motility,
is that Apaf1 might interact with centrosomal proteins. Strikingly,
one of the known Apaf1 interactors, HCA66, has been found very
recently to be localized into centrosomes (Fant et al., 2009).
Therefore, we examined whether Apaf1 depletion could affect
the localization of HCA66. By immunofluorescence assays of
WT I-Mefs, we found that HCA66 was highly dispersed in the
cytosol and that its localization to centrosomes was affected in
Apaf1-deficient cells (Fig. 9A,B). The same result was found in
ETNA cells (data not shown).
We then analyzed the effect of Apaf1 deficiency on HCA66
protein levels and found, surprisingly, that HCA66 increased in I-
Mefs (Fig. 9C) and also in ETNA cells (data not shown). In sum,
we observed that, in the absence of Apaf1, there was an increased
expression of HCA66, which was associated with its decreased
centrosomal localization. Because centrosomes are intimately
connected with the nuclear envelope, we decided to test the
association of HCA66 with the nuclear envelope in WT and
Apaf1-deficient I-Mefs at the biochemical level. To this aim, we
isolated nuclei of I-Mefs by nuclear–cytosolic fractionation. The
Fig. 5. Centrosomal microtubule
nucleation is impaired in Apaf1-
deficient cells. (A) Staining of I-Mefs
to visualize F-actin using TRITC–
phalloidin (red). Nuclei were stained
with DAPI (blue). Scale bar: 20 mm.
(B) Immunofluorescence staining of
microtubules in I-Mefs and ETNA
cells with an anti-b-tubulin antibody
(green). Arrows indicate microtubule
asters (WT). Asters are barely visible
in Apaf1-deficient cells (KO). Scale
bar: 10 mm. (C) Microtubule regrowth
assay in I-Mefs. Cells were cold
treated for 1 hour to achieve
depolymerization of microtubules, then
they were re-heated for 0 or 3 minutes
at 37 C˚ to allow microtubules re-
growth. Cells were then fixed and the
microtubules stained with an anti-b-
tubulin antibody (green). Scale bar:
5 mm.
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nuclei-containing pellets were extracted with detergents at low
salt concentration (1% Triton X-100), the extracts were
centrifuged and supernatants (S) and pellets (P) were analyzed
by western blotting (Padmakumar et al., 2005) to determine the
distribution of HCA66 (Fig. 9D). The distribution of the well-
characterized inner nuclear envelope protein lamin A/C served as
a control. We observed that, under the conditions used, lamin
A/C is completely resistant to extraction (Fig. 9D, lanes P).
Resistance to solubilization and presence in the pellet indicates
that a protein is an integral membrane protein with a tight
interaction with lamina A/C. Centrosomal proteins are bound to
the outer nuclear envelope membrane and are easily solubilized
by mild extraction conditions. Indeed, c-tubulin (used as a
marker of the centrosomes) is found in both the pellet and the
soluble fraction, and HCA66 has the same distribution.
Interestingly, in Apaf1-deficient cells, soluble HCA66 is more
abundant than in WT cells, whereas the pellet fraction is similar
in the two genotypes, meaning that, in Apaf1-depleted cells,
HCA66 (although more expressed) is more loosely bound to the
nuclear envelope than it is in WT cells (Fig. 9D). We found the
Fig. 6. Efficient centrosome and mitotic spindle formation
requires Apaf1. (A) Immunofluorescence staining of c-tubulin
(red) and DAPI staining in WT and KO I-Mefs. Scale bar:
5 mm. (B) Immunofluorescence staining of c-tubulin (red) in
WT and KO ETNA cells. Scale bar: 5 mm. (C) I-Mefs and
(D) ETNA cells were stained with anti-b-tubulin antibody
(green) to monitor the microtubule organization, with an anti-
phosphorylated histone H3 antibody (red), and DAPI dye (blue)
to visualize DNA. Scale bar: 10 mm. Spindle organization and
DNA alignment were used as criteria to define the mitotic
phenotype. (E) ImageJ quantitative analysis of the intensity of
c-tubulin immunofluorescence at the centrosomes shown in A
and B. At least 60 centrosomes were analyzed for each cell type
in two independent experiments. Values are means¡ s.e.m. for
both WT and KO cells. (F) Quantification of the spindle
phenotype in WT and KO I-Mefs and ETNA cells (n53).
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same results in ETNA cells (Fig. 9D), and also by using more
stringent extraction conditions (1% Triton X-100, 250 mM NaCl;
data not shown). Notably, in the pellet fraction, HCA66 has a
faster electrophoretic mobility compared with the HCA66 in the
soluble fraction.
Also, we evaluated the amount of other centrosomal proteins
and we observed that the centrosomal localization of NEDD1,
ninein and Cep192 was reduced in both Apaf1-deficient cell lines
(Fig. 9E,F, and data not shown), whereas pericentrin and PCM-1
appeared unaffected. To prove that the centrosome impairment
found in Apaf1-KO cells can also affect cytochrome c release,
we performed RNA silencing of NEDD1 in WT I-Mefs
(supplementary material Fig. S2). We observed that the partial
depletion of NEDD1 enhances cytochrome c release under
tunicamycin treatment (supplementary material Fig. S2C).
Taken together, these analyses suggest that Apaf1 might exert
its role in regulating centrosomal stability and the localization of
a number of centrosomal proteins through its effect on HCA66
localization.
When overexpressed, Apaf1 localizes to the outer
nuclear envelope
In order to explain how Apaf1 regulates the recruitment of
HCA66 to centrosomes, we hypothesized that Apaf1 might
Fig. 7. Apaf1-deficient cells have longer mitosis
and increased basal non-apoptotic cell death.
(A,B) Time-lapse analysis of dividing WT and KO
I-Mefs (A) or WT and KO ETNA cells (B) was
performed and one representative example for each
cell line is reported. The length of mitosis was
measured starting from the very early detachment of
the cell from the dish until the appearance of the two
new cells (arrow). The corresponding histograms
show the calculated duration of mitosis for each cell
line. Values are means ¡ s.e.m. of 30 mitotic cells
for each cell line. Scale bar: 20 mm. (C) DNA
content of cells as determined by propidium iodide
staining of the indicated cell lines in the absence of
toxic stimuli. Besides the G1 phase (2N) and the
G2–M phase (4N) cells, note the subG1 population
indicative of dead cells. The data are representative
of three separate experiments.
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localize to the centrosomes, interacting with HCA66. Therefore,
we performed an immunofluorescence analysis of overexpressed
Apaf1 (because the endogenous one is universally recognized as
undetectable by this technique), but we did not find any
centrosomal localization of this protein. Very interestingly,
however, we found overexpressed Apaf1 to be highly localized
on the outer nuclear envelope and ER, showing a pattern very
similar to that of the ER marker protein disulfide isomerase (PDI;
Fig. 10A–C). As a negative control, we overexpressed an
unrelated protein that does not have a nuclear envelope or ER
localization (superoxide dismutase 1; SOD1), and we performed
exactly the same procedure used for Apaf1 detection (Fig. 10B).
The specificity of the Apaf1 localization assay was also
confirmed by the fact that upon simultaneous exogenous Apaf1
Fig. 8. Cell migration and centrosome re-orientation in wound healing assays. (A) Migration of WT and KO I-Mefs into a scratch wound was monitored by
live-cell imaging. Scale bar: 50 mm. (B) Cells were fixed and stained with DAPI soon after the scratch and after 15 hours to evaluate the migration ability of
Apaf1-depleted I-Mefs into the wound. Scale bar: 300 mm. (C) In order to analyze centrosome re-orientation (arrows) towards a scratch wound, I-Mefs were fixed
and stained with anti-c-tubulin and anti-b-tubulin 30 minutes after introduction of the scratch wound. Centrosomes have been marked with white dots to highlight
their position. The white dashed line indicates the scratch direction. The percentage of cells with centrosomes that are directed toward the wound edge 30 minutes
after introduction of the scratch wound is indicated at the bottom right. 200 cells of either cell type were analyzed. Scale bar: 25 mm.
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transfection, small interfering RNA (siRNA) for Apaf1 strongly
reduces the expression of Apaf1 (supplementary material Fig.
S3). If Apaf1 plays a role in the nuclear envelope structure,
nuclear morphology could be altered in Apaf1-KO cells. Indeed,
we observed that nuclei in Apaf1-deficient cells are larger
(Fig. 10D, length and breadth) and that the DAPI signal intensity
(represented by the average gray factor) is lower, suggesting that
the chromatin packing is loose in this context. This difference
was also detected in ETNA cells (data not shown). Interestingly,
upon reintroduction of Apaf1 by transfection, we observed a
recovery of the normal nuclear size and DAPI intensity
(Fig. 10D, KO+Apaf1).
Discussion
Besides mitochondrial cell death regulation, Apaf1 has other
functions not related to apoptosis, which, upon DNA damage,
cause cell cycle arrest and DNA damage checkpoints (Zermati et
al., 2007). Here we show that Apaf1 also plays a role in normal
conditions (i.e. unrelated to its pro-apoptotic role) and not only
upon DNA damage induction or other stress stimuli. We have
Fig. 9. Apaf1 deficiency reduces
HCA66 and other centrosomal
protein recruitment to centrosomes.
(A) Immunofluorescence staining of
HCA66 (red) and b-tubulin (green) in
WT and KO I-Mefs (two representative
images for each genotype are shown).
Merged images of the two staining is
also shown. Scale bar: 5 mm.
(B) Quantitative analysis of the
intensity of HCA66
immunofluorescence at the centrosomes
(using ImageJ). At least 60 centrosomes
were analyzed for each genotype in
several images collected in two
independent experiments. Values are
means ¡ s.e.m. (C) Western blot
analysis of HCA66 expression in total I-
Mef lysates. b-actin was assayed as
loading control. (D) Solubilization
properties of HCA66 in WT and KO
cells. Purified nuclei of I-Mefs and
ETNA cells were isolated by nuclear–
cytosolic fractionation and were then
extracted in the same buffer containing
1% Triton X-100. The extracts were
centrifuged and supernatants (S) and
pellets (P) were analyzed by western
blotting to determine the location of
HCA66. Lamin A/C was used as a
control for the location of the inner
nuclear envelope, and c-tubulin as a
centrosome marker. Immunoblots are
from one experiment representative of
three that gave similar results. Cell
densities were calculated using the
software AlphaEaseFC, normalized for
c-tubulin and reported as arbitrary units
(a.u.). Values are means ¡ s.e.m. of
three independent immunoblots.
(E) Immunofluorescence staining of
NEDD1, PCM-1 (green), pericentrin,
ninein and Cep192 (red) in WT and KO
I-Mefs. NEDD1 was also analyzed in
ETNA cells. Scale bar: 5 mm.
(F) Quantitative analysis of the intensity
of NEDD1, PCM-1, pericentrin, ninein
and Cep192 immunofluorescence at the
centrosomes was performed using
ImageJ software. At least 60
centrosomes were analyzed for each
marker in several collected images.
Values are means ¡ s.e.m.
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found that the absence of Apaf1 impairs centrosome stability and
affects basic cellular processes such as spindle formation,
mitosis, mitochondrial morphology (the impairment of which
has been reported to increase the responsiveness of cells to stress)
and cell migration, thus causing the higher fragility of Apaf1-
deficient cells compared with WT cells.
In the first part of the paper we have shown that Apaf1
deficiency induces a lower expression of the anti-apoptotic
proteins Bcl-2 and Bcl-XL, which contributes to explaining
(together with the high degree of mitochondrial fission we
observed) the ease with which Apaf1-deficient cells release
cytochrome c (Figs 1–3). Low levels of Bcl-2 and Bcl-XL
increase permeabilization of mitochondria, leading to a lower
threshold in the stress response and a higher fragility of Apaf1-
deficient cells compared with WT cells. However, they do not
enhance apoptosis, because Apaf1 depletion impairs apoptosis.
Therefore, upon strong toxic insults, even though Apaf1-KO cells
are faster in responding to the insults and in initiating the
apoptotic pathway, they do not die, unlike WT cells. Sublethal
insults for WT cells might turn out to be sufficient to stimulate
the first stages of the apoptotic signaling in KO cells, because
they are more sensitive to stress. However, despite the fact that
Apaf1-KO cells do not complete apoptosis, over time, if the toxic
stimulus is continuous, a combination of Drp1-dependent
fragmented mitochondria, low levels of anti-apoptotic proteins,
fast cytochrome c release and aberrant mitosis (characterizing
Apaf1-deficient cells) could ultimately induce other forms of cell
death and, under conditions that are sublethal for WT cells,
Apaf1-KO cells will paradoxically show higher cell death than
WT cells do (Fig. 7C).
We set out to investigate the reasons for Apaf1-deficient cell
fragility and we found that the prosurvival role of Apaf1 could be
due, at least in part, to its effect on centrosome stability and
microtubule nucleation, which affect mitochondrial network
shape, spindle formation and mitosis (Figs 4–7). Moreover, it is
known that spindle aberrations can cause chromosome instability
(Fukasawa, 2007). In fact, among ETNA2/2 cells we have
observed a substantial number of multinucleated cells with
several centrosomes and an increased number of micronuclei,
which suggests chromosome segregation defects (see
supplementary material Fig. S1). Gain or loss of chromosomes
greatly accelerates tumor progression (Fukasawa, 2007), and it
has been suggested that the correlation between Apaf1 deficiency
and cancer might be not only due to the absence of apoptosis but
also to the absence of checkpoints (Zermati et al., 2007). In
addition, we propose that this effect might also be related to the
chromosome instability caused by microtubule and spindle
defects.
Fig. 10. Overexpressed Apaf1 is partially located on the outer
nuclear envelope and on the ER and restores the normal nuclear
size. (A) Immunofluorescence detection of overexpressed Apaf1
(green) in WT I-Mefs. (B) Immunofluorescence detection of
overexpressed SOD1 (red) in WT I-Mefs. (C) Immunofluorescence
detection of overexpressed Apaf1 (green) and PDI (red), and merged
images of both, in WT I-Mefs. Two representative images are shown.
Scale bar: 10 mm. (D) Analysis of nuclei size in I-Mefs; length,
breadth and average gray of nuclei of WT cells, Apaf1-KO cells and
Apaf1-KO cells overexpressing Apaf1 were measured using
Metamorph software. The average gray is a measure of the DAPI
signal intensity. For each experimental condition, at least 52 cells
were analyzed and data are presented as means¡ s.e.m. According
to Student’s t-test, all results are statistically significant.
Journal of Cell Science 124 (20)3460
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
We wanted to unravel how Apaf1 acts on centrosomes. We
discovered that, in the absence of Apaf1, recruitment of HCA66
to the centrosome is reduced (Fig. 9A,B,D); such a reduction has
previously been reported as causing disorganized microtubule
nucleation from centrosomes (Fant et al., 2009). Because HCA66
is an Apaf1 interactor, the lack of their binding might account for
the dysregulation of HCA66 centrosomal localization we
observed in the absence of Apaf1. Interestingly, the phenotype
we describe in Apaf1-KO cells is very similar, although milder, to
that reported for HCA66 KO cells, which includes spindle
microtubule assembly defects (Fant et al., 2009). The higher
levels of HCA66 in Apaf1-deficient cells (Fig. 9C) might be a
response of the cell aimed at counteracting the poor centrosomal
localization of HCA66.
We also found that the Apaf1-KO phenotype shows a striking
similarity to the knockout phenotype of the Golgi protein GM130
(Kodani and Sutterlin, 2008). On the basis of this phenotype
(which includes aberrant spindle formation, centrosome
dysmorphology and defective microtubule organization and cell
migration), this protein has been defined as a regulator of
centrosome morphology and function.
The effect of Apaf1 absence on HCA66 centrosomal
localization would be easily explained if Apaf1 had localized
to the centrosomes. However, we could not observe a
centrosomal localization of overexpressed Apaf1 (Fig. 10A,C).
Of note, overexpressed HCA66 was also not detectable within the
centrosomes (data not shown), whereas endogenous HCA66 was
clearly centrosomal (see Fig 9A); therefore, we cannot rule
out a centrosomal localization of endogenous Apaf1. Very
interestingly, when we overexpressed Apaf1 in cells, besides a
diffuse presence into the cytosol, we also detected a clear
localization of this protein to the ER and also to the ER region
forming the outer layer of the nuclear envelope (Fig. 10A,C).
Indeed, although most studies continue to report Apaf1 as being
diffuse into the cytosol (Hausmann et al., 2000; Wang, 2001),
some show a perinuclear and Golgi localization of Apaf1 (Ruiz-
Vela et al., 2001) or its localization in membrane domains at or
near the plasma membrane (Sun et al., 2005). There have also
been other reports of nuclear accumulation of Apaf1 and
perinuclear accumulation of its nematode ortholog CED-4
(Caenorhabditis elegans death-promoting protein-4) upon DNA
damage (Besse et al., 2004; Ruiz-Vela et al., 2002; Zermati et al.,
2007).
Because it is known that centrosomes are intimately connected
with the nuclear envelope (reviewed by Gonczy, 2004), and that
proteins from the outer nuclear envelope regulate the
composition of the centrosome (Malone et al., 2003;
Salpingidou et al., 2007), the localization of overexpressed
Apaf1 at the outer envelope suggests that it might interact there
with HCA66, and favor the recruitment of HCA66 to the
centrosomes. We observed that, upon nuclear extraction, HCA66
in the nuclear soluble fraction (Fig. 9D) has a lower molecular
mass than that isolated from the pellet (Fig. 9D), an effect that is
most probably due to a post-translational modification. Because
the low molecular mass HCA66, which weakly bound to the
nucleus, is more abundant in conditions of Apaf1 deficiency
(Fig. 9D), we speculate that, in the absence of Apaf1, HCA66 is
not efficiently modified and, in turn, it might have more difficulty
in being recruited to the centrosomes or, vice versa, it is less
efficiently recruited to centrosomes and thus less efficiently
modified.
The outer membrane localization of Apaf1 might also have a
structural role on the nuclear envelope, which becomes loose in
its absence, so influencing nuclear size; in fact, Apaf1-deficient
nuclei are larger and chromatin is more loosely packaged
(Fig. 10D). This might be another explanation for the weakness
of Apaf1-deficient cells, because nuclei might be more sensitive
to physical stress.
To sum up, we report here a novel prosurvival role for Apaf1,
which we showed to be partly localized at the ER and outer
nuclear envelope. We discovered that Apaf1, through its binding
and regulation of HCA66 centrosomal localization, participates
in regulating centrosomal microtubule nucleation and therefore
also spindle assembly, cell migration and mitochondrial network
organization. Although the exact molecular mechanism of this
regulation needs to be understood in more depth, this finding
suggests challenging new scenarios regarding the regulation of
the equilibrium between cell death and survival.
Materials and Methods
Plasmid constructs
Apaf1 expression plasmid was created by PCR cloning of murine Apaf1 cDNA
(Cecconi et al., 1998) from the plasmid described previously (Cozzolino et al.,
2004) between the ApaI and NotI sites of pShuttle (Clontech). SOD1 expression
plasmid was described elsewhere (Cozzolino et al., 2004).
Cell cultures and treatments
ETNA wild-type and ETNA2/2 cells were obtained as described elsewhere
(Cozzolino et al., 2004). They were routinely grown in DMEM (Gibco BRL) +
10% FBS (Gibco BRL), at 33 C˚ in an atmosphere of 5% CO2 in air. Mouse
embryonic fibroblasts (Mefs) were manually dissected from wild-type and
homozygous E13.5 embryos and cultured in DMEM supplemented with 10%
FBS at 37 C˚. Mefs were immortalized with SV40 antigen. ETNA cells stably
expressing dominant negative caspase-9 (C9DN-ETNA) were obtained as
described previously (Ferraro et al., 2008). To induce apoptosis, I-Mefs were
treated with 2 mg/ml tunicamycin or 10 mM actinomycin D for 20 hours. ETNA
cells were treated with 20 mM actinomycin D or 3 mg/ml tunicamycin for 24 hours,
then MG132 (2 mM) was added for a further 40 hours.
Immunocytochemistry
Cells cultured in 35-mm Petri dishes were washed in PBS and fixed with
methanol–acetone at –20 C˚ for 10 minutes or with 4% PFA in PBS for 15 minutes.
After permeabilization with 0.4% Triton X-100 in PBS for 5 minutes (performed
only after PFA fixation), cells were blocked in 2% horse serum in PBS and
incubated for 1 hour at 37 C˚ with primary antibodies. The following antibodies
were used: anti-cytochrome c (clone 6H2.B4; Assay Designs), anti-b-tubulin
(Sigma-Aldrich), anti-NEDD1 (Abcam) monoclonal antibodies and anti-MnSOD1
(Stressgen), anti-Apaf1 (BD Transduction Laboratories), anti-PDI (Stressgen),
anti-c-tubulin (Sigma-Aldrich), anti-HCA66, anti-ninein, anti-PCM-1 (three kind
gifts from A. Merdes, CNRS-Pierrre-Fabre, Toulouse, France), anti-pericentrin (a
kind gift from T. Davis, University of Washington, Seattle, WA) anti-Cep-192 (a
kind gift from L. Pelletier, University of Toronto, Toronto, ON, Canada) and anti-
phosphohistone H3 (Upstate) polyclonal antibodies. Cells were then washed in
blocking buffer and incubated for 1 hour with labeled anti-mouse (Alexa Fluor 488
or Alexa Fluor 555; Molecular Probes) or anti-rabbit (FITC or Cy3; Jackson
ImmunoResearch) secondary antibodies. After rinsing in blocking buffer, cell
nuclei were stained with 1 mg/ml DAPI and examined under a Leica TCS SP5
confocal microscopy. Fluorescence images were adjusted for brightness, contrast
and color balance using Adobe Photoshop CS.
Immunoblotting
After rinsing the cultures with ice-cold PBS, cell lysis was performed in RIPA buffer
(20 mM Tris-HCl, pH 7.4, 1% Triton X-100, 150 mM NaCl, 1 mM EDTA, 5 mM
MgCl2) containing a protease inhibitor cocktail (Sigma-Aldrich). A clear supernatant
was obtained by centrifugation of lysates at 13,000 g for 10 minutes. Protein content
was determined using the Bradford protein assay (Bio-Rad). Western blots were
performed on polyvinylidene difluoride membranes (Immobilon P; Millipore). Equal
loading of samples was confirmed by b-actin (Sigma-Aldrich) or voltage-dependent
anion-selective channel protein (VDAC; Calbiochem) normalization. Polyclonal
anti-Bcl-X S/L (S-18), anti-lamin A/C (N-18) and anti-Tom20 (FL-145) antibodies
were purchased from Santa Cruz Biotechnology. To detect Drp1, a monoclonal
antibody (anti-Dlp1, clone 8) from BD Biosciences or from Cell Signaling and a
polyclonal antibody anti-phospho-Drp1 (Ser 616) from Cell Signaling were used.
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Monoclonal antibodies, anti-Apaf1 and anti-Bcl2, were purchased from BD
Biosciences and Santa Cruz Biotechnology, respectively. A polyclonal antibody,
anti-c-tubulin, was purchased from Sigma-Aldrich and a polyclonal antibody, anti-
HCA66, was a kind gift form A. Merdes (CNRS-Pierrre-Fabre, Toulouse, France).
Real-time RT-PCR
RNA was isolated using an RNeasy Micro Kit (Qiagen Inc), according to the
manufacturer’s instructions. For RT-PCR, first strand cDNA was synthesized with
esaprimers by adding 1 mg of RNA with M-MLV reverse transcriptase
(Invitrogen). Real-time PCR was performed by using SensiMix Plus SYBR Kit
(Quantace Ltd). The following primers were used: mouse Bcl-xL forward 59-
GGTGAGTCGGATTGCAAGTT-39, reverse 59-AAGAGTGAGCCCAGCAG-
AAC-39; mouse Bcl-2 forward 59-GTACCTGAACCGGCATCTG-39, reverse 59-
GGGGCCATATAGTTCCACAA-39. Real-time quantification was performed by
using a Fast Real-Time PCR System (Applied Biosystems). Data were normalized
to b-actin (forward 59-AGCCATGTACGTAGCCATCC-39, reverse 59-CTCT-
CAGCTGTGGTGGTGAA-39). Fold change was determined by using the 22DDCT
method (Livak and Schmittgen, 2001). All reactions were performed in triplicate.
Time-lapse video microscopy
A Zeiss Axiovert-35 microscope equipped with a JVC digital CCD camera and
IAS2000 software (Deltasistemi, Rome, Italy) was used to take images every
5 minutes for an observation period of 20 hours. Applying the ‘visualize’ mode,
these series of photographs were displayed as continuous time-lapse movies. Cells
were seeded the day before recording into 35-mm dishes. Temperature was
adjusted to 33 C˚ or 37 C˚ with a Peltier apparatus. A 506 magnification was
applied.
Wound healing assay
Cells were seeded the day before recording as a confluent monolayer onto 35 mm
dishes. Scratch wounds were introduced using a pipette tip and medium was
changed to remove debris and mitotic cells. Time-lapse video microscopy was then
performed to monitor the wound healing.
Microtubule regrowth assay
The medium of cells grown on 35-mm dishes was changed with precooled medium
and cells were transferred onto ice for 1 hour and then into prewarmed medium at
37 C˚. Regrowth was stopped after 3 minutes by methanol–acetone fixation.
Analysis of cell viability
Adherent and detached cells were combined and stained with 50 mg/ml propidium
iodide before analysis using a FACScalibur instrument (BD Biosciences).
Apoptotic cells were evaluated by calculating peak areas of hypodiploid nuclei
in previously premeabilized cells (subG1).
Nuclear–cytosolic fractionation
Cells were detached from the dish with trypsin and washed with PBS. Pellets were
incubated in ,5 vol. ice-cold hypotonic buffer (10 mM Hepes pH 7.4, 5 mM
MgCl2, 10 mM NaCl, 1 mM DTT) containing a protease inhibitor cocktail
(Sigma-Aldrich) and the phosphatase inhibitors Na3VO4 (1 mM) and NaF (1 mM),
and homogenized in a glass–glass homogenizer (Dounce homogeniser) using 100
strokes of a tight-fitting pestle. The soluble cytoplasmic, and the insoluble nuclear
fractions were separated by centrifugation at 2000 g for 10 minutes at 4 C˚. The
pellets containing the nuclei were extracted in the same buffer containing either
1% Triton X-100 or 1% Triton X-100 and 250 mM NaCl. The extracts were
centrifuged at 15,000 g for 10 minutes at 4 C˚ and supernatants and pellets were
analyzed by western blotting.
Mitochondrial fractionation
Subcellular fractionation was performed as previously described (Frezza et al.,
2007). Briefly cells were harvested with a cell scraper and homogenized with a
glass–Teflon potter in isolation buffer (10 mM Tris–Mops, 1 mM EGTA–Tris,
200 mM sucrose). Supernatant was collected after centrifuging at 600 g for
10 minutes. After centrifuging once more at 7000 g for 10 minutes the protein
concentration of the crude mitochondrial pellet was determined and equal amount
of protein were separated by SDS-PAGE.
Transfection procedures
Apaf1 and SOD1 expression plasmids and double-stranded siRNA oligomers were
transiently transfected using Lipofectamine2000 according to the manufacturer’s
instructions (Invitrogen). For Apaf1 and NEDD1 silencing we used the smart pool
siRNA directed against four NEDD1 and Apaf1 mRNA sequences specific for
mouse (Dharmacon). Their sequences are available on request. Control cells were
transfected with a scrambled siRNA duplex (Ambion), which does not show
homology with any other murine mRNAs.
Data presentation
All experiments were performed at least three times, unless otherwise indicated.
Data are expressed as means ¡ s.e.m. The significance of differences between
populations of data were assessed by Student’s t-tests and differences with P#0.05
were considered as significant.
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